By G HossainPosted on January 16, 2026Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs Following rusfertide’s triumphant Phase III trial last year, Protagonist must decide how involved to be in future development. Hundreds of millions of dollars are on the line. JPM26: Protagonist Has a $400M Decision To Make. It’s a No-Brainer Post navigation Speculation of Sanofi Takeover Sends Ocular’s Stock SoaringVedanta ‘Significantly’ Reduces Staff, Focuses on Phase III Study of C. Diff Drug